Chronic diseases such as thalassemia, sickle cell disease (SCD), anemia, and diabetes have been rising around the world. This has emerged as the foremost growth enabler of the global hemoglobin analyzer market. With the growing incidence of life-threatening blood disorders, the demand for hemoglobin analyzers is set to increase in the coming years. As a result, prominent industry leaders...